(Reuters) -Drugmaker Pfizer posted a better than expected fourth quarter profit on Thursday, helped by cost cuts and a ...

Pfizer shares, which had risen Tuesday morning after improved demand for the Covid vaccine, dropped 2.3% after Kennedy's ...

The Food and Drug Administration (FDA) recently gave approval for clinical trials in the U.S. of a COVID-19 nasal vaccine ...

A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...

Michigan's largest health system urges patients to seek nonemergency care at sites other than its ERs amid a surge in flu, ...

RSV, respiratory syncytial virus, usually peaks in December and January while infecting the nose, throat and lungs, usually ...

After a brief moment when Americans came together to battle a virus, the pandemic accelerated divisions of all kinds. If it ...

Dr Sonali Mukherjee-Bose told a colleague there would be ‘no risk and good remuneration’ if they created the fake documents ...

Health experts are seeing signs of a much smaller wave of U.S. COVID-19 cases this winter than in previous years, which could ...

Many nursing home residents are refusing COVID shots this winter, though flu vaccine penetration has remained strong historically.

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...